There were many positive discussions about the future of our brand, and we were grateful to be able to create some lasting connections that will truly benefit our company
Boca Raton, FL (PRWEB) January 20, 2017
URSAPHARM, a German company dedicated to developing a range of high-quality medicinal products, announced it attended this month’s ECRM trade show, which took place in Hilton Head, SC.
URSAPHARM has made its name by developing a range of natural products that benefit the immune system. Its Aronia + Immune product is a highly regarded nutraceutical containing vitamins and micronutrients from the Aronia berry, commonly known as the chokeberry. At this ECRM trade show, the company will had the opportunity to explain the benefits of its product in depth to some of the country’s foremost retail buyers.
“We were thrilled to have the opportunity to attend this ECRM trade show,” said Uwe Hurth, the area manager for America, Asia and the Pacific for URSAPHARM. “Not often do you get the chance to meet face-to-face in a private setting with retail buyers that have such clout in the industry. We were able to discuss our product, its potential and steps to move forward with our marketing strategy with some of the foremost thought leaders in our industry.”
Aronia berry juice, the primary active ingredient in URSAPHARM’s Aronia + Immun, is extremely high in antioxidants, has a high anthocyanin concentration, and is extremely high in tannins. Aronia berries have also been the subject of scientific research about their phytonutrients. Studies indicate regular consumption of these berries helps reduce blood pressure, inflammation, weight gain, eye inflammation, muscle recovery time and chances of developing cancer.
ECRM events feature closed-session, private meetings between vendors and buyers about a variety of topics, such as product launches, marketing strategies and more.
“There were many positive discussions about the future of our brand, and we were grateful to be able to create some lasting connections that will truly benefit our company,” said Hurth.
For more information about URSAPHARM, visit http://www.ursapharm.de/en.